CVE-2026-21997HIGH 8.5EPSS p10.1%

CVE-2026-21997CVE-2026-21997

Description

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

Scoring

CVSS 3.18.5 (HIGH)
VectorCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N
EPSS0.20% probability of exploitation · percentile 10.1% · 2026-06-19T12:03:05Z
Published2026-04-21
Last modified2026-05-01

Underlying weaknesses· 1

CWE-284

References

  1. https://www.oracle.com/security-alerts/cpuapr2026.html

1

TypeTargetConfidenceTier
WeaknessImproper Access Controlcwe-2840%live

Related by meaning· 6

Nearest entities by semantic similarity across the cs-graph corpus.

CVE
CVE-2026-21973
CVE
CVE-2026-21962
CVE
CVE-2026-21969
CVE
CVE-2026-21994
CVE
CVE-2026-34291
CVE
CVE-2026-21992
Sourced from NVD + FIRST.org EPSS. Curated for EU compliance use cases by Adam Lundqvist, Founder at SQUR.